- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00444067
Study to Evaluate Safety & Effectiveness of Spinal Sealant
A Prospective, Multi-Center, Randomized Controlled Study to Compare the Spinal Sealant System as an Adjunct to Sutured Dural Repair With Standard of Care Methods During Spinal Surgery
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Bedford, Massachusetts, United States, 01730
- Confluent Surgical, Inc.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Subjects scheduled for a spinal procedure that requires a dural incision
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Spinal Sealant System
|
Spinal Sealant System
|
Active Comparator: Standard of Care
Standard of care methods as an adjunct to sutured dural repair
|
Standard of Care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percent(%) Success in Obtaining a Watertight Closure Following Assigned Treatment (Spinal Sealant or Control)
Time Frame: Intra-operative
|
Percent(%) success in obtaining a watertight closure following assigned treatment (Spinal Sealant or Control) where success is defined as: A watertight closure of the dural repair intraoperatively after study treatment, confirmed by Valsalva maneuver at 20-25 cm H2O for 5-10 seconds. |
Intra-operative
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of Post-Operative CSF Leaks
Time Frame: 90 Days
|
Percentage of participants with CSF leaks within 90 days post-operatively as determined from clinical diagnosis by one of the following methods:
|
90 Days
|
Incidence of Post-Operative Surgical Site Infections (SSIs)
Time Frame: 90 Days
|
•Percentage of participants who incur an SSI within 90 days post-procedure determined by clinical diagnosis SSIs were diagnosed and classified in accordance with the Centers for Disease Control (CDC) criteria for evaluation and diagnosis of nosocomial surgical site infections and were classified as one of the following (Superficial, Deep or Organ/Space). |
90 Days
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Jen Doyle, Conlfuent Surgical/Covidien
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- DS3-06-002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cerebrospinal Fluid Leakage, Subdural
-
University of ZurichCompletedCerebrospinal Fluid LeakageSwitzerland
-
Kuros Biosurgery AGCompletedCerebrospinal Fluid LeakageGermany, Hungary
-
University of GuadalajaraCompleted
-
Assiut UniversityRecruiting
-
Rawalpindi Medical CollegeRecruiting
-
Wuhan Union Hospital, ChinaNot yet recruiting
-
Universitaire Ziekenhuizen KU LeuvenRecruitingCerebrospinal FluidBelgium
-
Wake Forest University Health SciencesCompletedCerebrospinal Fluid ShuntsUnited States
-
Indiana University3-D Matrix Medical TechnologyNot yet recruitingSkull Base Neoplasms | Cerebrospinal Fluid Leakage | Nasal; Hypertrophy, Mucous Membrane (Septum)United States
Clinical Trials on Standard of Care
-
Johns Hopkins UniversityRecruitingCompartment Syndrome of Leg | Extracorporeal Membrane Oxygenation Complication | Limb Ischemia, Critical | Limb IschemiaUnited States
-
brett rasmussenCompleted
-
Indonesia UniversityCompletedCovid19 | AcupunctureIndonesia
-
Aventusoft, LLC.National Heart, Lung, and Blood Institute (NHLBI); Cleveland Clinic FloridaRecruitingHeart Failure (HF)United States
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsCompletedSevere COVID-19Israel
-
Ruijin HospitalRecruitingCOVID-19 PneumoniaChina
-
Institut Claudius RegaudCompletedMETASTATIC CANCERFrance
-
Ziv HospitalNot yet recruiting
-
Hofseth Biocare ASAKGK Science Inc.CompletedCovid-19 | COVIDCanada, Brazil, Hungary, Mexico, Serbia
-
City University of New York, School of Public HealthNew York State Psychiatric Institute; University of KwaZulu; International Initiative... and other collaboratorsCompleted